Biomarker Qualification Draft Guidance From FDA May Itself Need Refining
Executive Summary
Biomarkers in bodily fluids and tissue samples raise different questions, so the FDA draft guidance on the use of histology to qualify them should make the distinction clearly, Sandra Gaston, Harvard Medical School, said.